Point72 Hong Kong’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-571
| Closed | -$23.1K | – | 438 |
|
2025
Q1 | $23.1K | Buy |
+571
| New | +$23.1K | ﹤0.01% | 383 |
|
2022
Q3 | – | Sell |
-398
| Closed | -$4K | – | 1364 |
|
2022
Q2 | $4K | Sell |
398
-1,844
| -82% | -$18.5K | ﹤0.01% | 1290 |
|
2022
Q1 | $32K | Buy |
+2,242
| New | +$32K | ﹤0.01% | 954 |
|
2021
Q4 | – | Sell |
-650
| Closed | -$15K | – | 1302 |
|
2021
Q3 | $15K | Sell |
650
-2,073
| -76% | -$47.8K | ﹤0.01% | 1135 |
|
2021
Q2 | $68K | Buy |
2,723
+2,464
| +951% | +$61.5K | ﹤0.01% | 844 |
|
2021
Q1 | $8K | Sell |
259
-336
| -56% | -$10.4K | ﹤0.01% | 1089 |
|
2020
Q4 | $15K | Buy |
595
+29
| +5% | +$731 | ﹤0.01% | 1008 |
|
2020
Q3 | $17K | Buy |
566
+202
| +55% | +$6.07K | ﹤0.01% | 896 |
|
2020
Q2 | $9K | Buy |
364
+334
| +1,113% | +$8.26K | ﹤0.01% | 985 |
|
2020
Q1 | $1K | Sell |
30
-302
| -91% | -$10.1K | ﹤0.01% | 863 |
|
2019
Q4 | $7K | Buy |
+332
| New | +$7K | ﹤0.01% | 1003 |
|
2019
Q3 | – | Sell |
-4,008
| Closed | -$77K | – | 966 |
|
2019
Q2 | $77K | Buy |
+4,008
| New | +$77K | 0.02% | 544 |
|